1. Home
  2. IBRX vs GOLF Comparison

IBRX vs GOLF Comparison

Compare IBRX & GOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

N/A

Current Price

$7.94

Market Cap

6.1B

Sector

Health Care

ML Signal

N/A

Logo Acushnet Holdings Corp.

GOLF

Acushnet Holdings Corp.

N/A

Current Price

$93.06

Market Cap

4.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
IBRX
GOLF
Founded
2014
1910
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
4.9B
IPO Year
2015
2016

Fundamental Metrics

Financial Performance
Metric
IBRX
GOLF
Price
$7.94
$93.06
Analyst Decision
Strong Buy
Hold
Analyst Count
7
7
Target Price
$12.57
$83.67
AVG Volume (30 Days)
31.4M
364.9K
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
1.10%
EPS Growth
38.71
N/A
EPS
N/A
3.11
Revenue
$113,288,000.00
$1,633,721,000.00
Revenue This Year
$88.57
$5.01
Revenue Next Year
$146.98
$3.57
P/E Ratio
N/A
$29.88
Revenue Growth
668.31
4.71
52 Week Low
$1.83
$55.31
52 Week High
$12.43
$104.81

Technical Indicators

Market Signals
Indicator
IBRX
GOLF
Relative Strength Index (RSI) 49.64 36.44
Support Level $2.27 $75.65
Resistance Level $8.28 $104.16
Average True Range (ATR) 1.03 3.28
MACD -0.33 -1.17
Stochastic Oscillator 3.33 17.49

Price Performance

Historical Comparison
IBRX
GOLF

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

About GOLF Acushnet Holdings Corp.

Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, and others. These products are offered through different brands such as Titleist, FootJoy, Scotty Cemeron, Vokey Design, Pinnacle, KJUS, and others. The company's reportable segments are Titleist golf equipment, FootJoy golf wear, and Gofl gear. A majority of its revenue is generated by the Titleist golf equipment segment. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Asia (EMEA), Japan, Korea, and the Rest of the world.

Share on Social Networks: